8th Euro Global Summit on Cancer Therapy
Prahlad V Raninga
Griffith University, Australia
Prahlad V Raninga has completed M Res at University of East Anglia, England, and currently pursuing PhD at Griffi th University, Australia. His main research interests include cancer biology, cell signaling and molecular cancer therapeutics. His current research is focused onto investigate the therapeutic potential of the antioxidant molecules to treat myeloma. He has published two fi rst author papers in the reputed oncology journals during his early PhD candidature.